Take a look at the businesses making headlines earlier than the bell: Pfizer — The pharma big issued disappointing 2026 earnings steering. Pfizer a revenue between $2.80 per share and $3 per share for the approaching 12 months. Analysts polled by LSEG anticipated earnings per share of $3.05 for 2026. The corporate additionally reaffirmed its 2025 outlook. Shares hovered across the flatline. Roku — The streaming platform rose greater than 4% after Morgan Stanley double upgraded the inventory to chubby from underweight. “Roku’s Platform income progress has accelerated in 2H25, suggesting that its scaled consumer base, plus stable execution on deepening streaming partnerships … place the corporate as a continued beneficiary of business tailwinds.” Kraft Heinz — The corporate introduced former Kellanova CEO Steve Cahillane will take the reins as chief government in 2026, as Kraft Heinz preps to interrupt up into two publicly traded entities. Shares have been up barely. Elanco Animal Well being — The pet vaccine maker rose 4% after CEO Jeffrey Simmons and CFO Robert VanHimbergen disclosed purchases, in keeping with regulatory filings. — CNBC’s Fred Imbert contributed reporting
